fluorodeoxyglucose f18 has been researched along with 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrosio, E; Desco, M; Lamanna-Rama, N; Leza, JC; López, G; MacDowell, KS; Soto-Montenegro, ML | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol
| Article | Year |
|---|---|
Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence.
Topics: Animals; Cannabinoid Receptor Agonists; Endocannabinoids; Female; Fluorodeoxyglucose F18; Glucose; Male; Morphine; Neuroimaging; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2023 |